Back
United Therapeutics Stock Predictions
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Buy
55
UTHR
United Therapeutics
Last Price:
351.25
Seasonality Move:
2.3%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.United Therapeutics Stock Forecast
- Over the next 52 weeks, United Therapeutics has on average historically risen by 26% based on the past 25 years of stock performance.
- United Therapeutics has risen higher in 18 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 72%
-
Is United Therapeutics Stock Undervalued?
The current United Therapeutics [UTHR] share price is $351.33. The Score for UTHR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal. - UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will United Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, United Therapeutics has on average historically risen by 26% based on the past 25 years of stock performance.
United Therapeutics Stock Rating
Buy
55
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics overpriced?
- United Therapeutics has risen higher in 18 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 72%
United Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
unither.com
52-Week Data
52-Week High:
366.08
52-Week Low:
208.62
Prediction Charts
Market Cap:
15.63B
Price in USD:
351.33
Volume:
431.49K
Beta:
0.53
Technical Analysis
SMA50:
337.76
SMA100:
311.03
SMA200:
270.17
52-Wk Change:
59.21%
Stock Predictions
-
Is United Therapeutics stock public?
Yes, United Therapeutics is a publicly traded company. -
What is the United Therapeutics stock quote today?
The United Therapeutics stock price is 351.33 USD today. -
How to buy United Therapeutics stock online?
You can buy United Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-30 | 360.22 | 363.55 | 364.45 | 359.29 |
| Sep-3 | 362.37 | 352.30 | 366.08 | 352.06 |
| Sep-4 | 352.65 | 353.37 | 354.95 | 349.57 |
| Sep-5 | 351.29 | 350.24 | 353.01 | 347.62 |
| Sep-6 | 349.76 | 345.66 | 351.64 | 345.33 |
| Sep-9 | 345.41 | 348.71 | 349.35 | 344.02 |
| Sep-10 | 348.10 | 342.46 | 348.10 | 340.46 |
| Sep-11 | 343.00 | 346.19 | 347.21 | 340.00 |
| Sep-12 | 345.77 | 341.11 | 345.77 | 340.65 |
| Sep-13 | 341.69 | 339.12 | 347.29 | 337.52 |
| Sep-16 | 339.12 | 344.98 | 345.47 | 338.41 |
| Sep-17 | 341.92 | 345.02 | 353.63 | 341.92 |
| Sep-18 | 344.57 | 342.59 | 347.57 | 342.03 |
| Sep-19 | 345.46 | 351.33 | 353.04 | 344.47 |
United Therapeutics Earnings
United Therapeutics Earnings Report: Per Share United Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
United Therapeutics Forecast Revenue Growth
United Therapeutics Stock Analysis: Historical quarterly revenues per share for United Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $1.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.87 per share, and an increase next year of $1.42 per share.
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.